Alasdair Macdonald

Founded in 1993, IQVIA IES Overseas Holdings Ltd. is a part of Quintiles Transnational Corp. and functions as an investment holding British company. The company is based in Reading, UK.

Founded in 1988, IQVIA IES Europe Ltd. is a subsidiary of IQVIA Holdings, Inc. The company is based in Reading, UK. The British company provides solutions to help life sciences organizations drive healthcare forward and get the right treatments to patients, faster.

IQVIA Ltd. provides professional services, information and partnering solutions. The firm serves its services to pharmaceutical, biotechnology, medical device and healthcare industries. It also provides contract research, sales, marketing, healthcare policy consulting and health information management services. The company was founded by Dennis Barry Gillings in 1995 and is headquartered in Reading, the United Kingdom.

Part of Quintiles Transnational Corp., IQVIA IES UK Ltd. is a healthcare company that leverages artificial intelligence (AI) and machine learning to help customers address their biggest challenges. The company is based in Reading, UK and was founded in 1995. The British company brings doctors, data scientists, engineers, and researchers together to build practical, scalable solutions. IQVIA solutions powered by AI and machine learning have moved beyond automation and process efficiency to uncover new insights and unlock new opportunities.

Serendipity Partners Management AS (Serendipity Partners) is a private equity/venture capital firm founded in 2015 by Michael Bodd. The firm is headquartered in Oslo, Norway.

Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm.

Cinclus Pharma AG is a Swiss Swedish pharmaceutical company founded in 2011. Cinclus Pharma is based in Basel, Switzerland. The private company is focused on bringing relief to people suffering from gastric acid related diseases, particularly gastroesophageal reflux disease (GERD). Cinclus Pharma's clinical stage drug candidate, linaprazan glurate, is a new approach to managing GERD and is showing promising results in acid control and lowering the cmax-value. The company was founded by experts in the field of GERD treatment with extensive experience from Astra and Astra Zeneca.

Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021.

Part of IQVIA Holdings, Inc., IQVIA Biotech Ltd. is a British company that provides medical research. The company is based in Reading, UK. Founded in 1997. IQVIA Biotech was acquired by PharmalinkFHI, Inc. on 2008-06-09.

Part of IQVIA Holdings, Inc., IQVA RDS Holdings functions as an investment holding British company. The company is based in Reading, UK. IQVA RDS Holdings was founded in 1992.

Smartfish AS is a holding company that creates drinks for special medical purposes, as well as for people on the go and top athletes to improve their recovery and immune response. It is a research-based company that develops omega 3 based emulsions for brain health, heart health, immune system, and recovery. The firm’s product NutriFriend medical nutrition is sold through pharmacies, medical wholesalers, and directly to hospitals. The company was founded by Janne Sande Mathisen and Henrik Mathisen in 2001 and is headquartered in Oslo, Norway.

Part of IQVIA Holdings, Inc., IQVIA RDS UK Holdings Ltd. functions as an investment holding company. The company is based in Reading, UK and was founded in 2009.

Part of IQVIA Holdings, Inc., IQVIA Investment Holdings Ltd. functions as an investment holding British company. The company is based in Reading, UK.

Part of IQVIA Holdings, Inc., IMS Hospital Group Ltd. is a British company that provides market research and public opinion polling services. The company is based in London, UK.

Part of IQVIA Holdings, Inc., IMS Information Solutions UK Ltd. is a company that provides business support services to the pharmaceutical industry. IMS Information Solutions UK Ltd. is based in London, UK. IMS Information Solutions was founded in 2000.

Founded in 1994, IMS Technology Solutions UK Ltd. is a dormant company that operates as a subsidiary of IQVIA Holdings, Inc. The company is based in London, UK.

IQVIA Solutions UK Ltd. engages in the provision of market research and consulting services for the pharmaceutical sector. The firm offers analytic, healthcare measurement and consulting solutions to different sectors such as pharmaceutical, payers, government, consumer health, providers, pharmacies, pharmaceutical distributors and financial communities. The company was founded on August 5, 1959 and is headquartered in London, the United Kingdom.

IQVIA Technology Services Ltd. provides information and technology services to the healthcare industry. It also supplies healthcare business intelligence solutions. The company was founded by Tom Mulhern in 1998 and is headquartered in Stafford, the United Kingdom.

Part of IQVIA Holdings, Inc., IQVIA World Publications Ltd. is a British company that provides solutions to help life sciences organizations drive healthcare forward and get the right treatments to patients faster. The company is based in London, UK. The company offers a range of services including strategic consulting, program design, technology support, data science and analysis, and quality assurance. The company aims to work more efficiently and effectively while reducing risks and costs, aligning with business goals such as launching new products, enhancing patient safety, collaborating with partners, and meeting regulatory requirements. Founded in 1973, IQVIA World Publications focuses on quality management in various areas of business, from R&D and clinical trials to manufacturing and distribution.

Founded in 1983, Dataline Software Ltd. is a British healthcare software development company. Part of IQVIA Holdings, Inc., the company is based in Reading, UK. The company develops software related to healthcare solutions. Dataline Software was acquired by IMS Health Holdings, Inc. on May 05, 2015.

Part of Smartfish AS, Smartfish AB is a Swedish company that focuses on medical nutrition for cancer patients. The company is based in Solna, Sweden. The company believes that good nutritional status is crucial for successful treatment and optimal outcomes. Smartfish has a slim and flexible organizational structure and aims to grow through strategic relationships with leading R&D, production, and distribution partners. The company's medical nutrition products are used to improve the nutritional status of malnourished or undernourished patients.

Artimplant AB engages in research and development of biomaterials for solutions to problems in orthopedic, odontological and reconstructive surgery. It also involves in the development, production and marketing of degradable implants designed to restore active lifestyles and improve quality of life. The company was founded by Anders Cedronius in 1990 and is headquartered in Vastra Frolunda, Sweden.

Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden.

Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA.

TFS Trial Form Support AB provides clinical trial services. The firm operates as a clinical contract research organization. Its services include regulatory affairs, feasibility, global clinical operations, study and site coordination, patient recruitment services, clinical data management, edc systems, biostatistics, pharmacovigilance/safety, medical writing, quality assurance, tfs academy, and functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lund, Sweden.

Apotek Produktion & Laboratorier AB develops and manufactures pharmaceutical products. Its services include analytical services, clinical trials and contract manufacturing. The company is headquartered in Kungens Kurva, Sweden.

Part of InDex Pharmaceuticals Holding AB, InDex Diagnostics AB manufactures pharmaceutical products. The company is based in Solna, Sweden. Peter Hakim Zerhouni has been the CEO of the Swedish company since 2015.

IQVIA Clinical AB delivers information and technology solutions for healthcare purposes. It specializes in primary care, hospital, and specialist products. The company was founded in 1984 and is headquartered in Solna, Sweden.

TFS Trial Form Support International AB provides clinical contract research services. It offers clinical development planning, regulatory affairs, medical informatics, study and site coordination, clinical data management, biostatistics, medical writing, and other functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lud, Sweden.

InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden.